Literature DB >> 24559646

miR-126 contributes to Parkinson's disease by dysregulating the insulin-like growth factor/phosphoinositide 3-kinase signaling.

Woori Kim1, Yenarae Lee2, Noah D McKenna2, Ming Yi3, Filip Simunovic2, Yulei Wang4, Benjamin Kong4, Robert J Rooney5, Hyemyung Seo6, Robert M Stephens3, Kai C Sonntag7.   

Abstract

Dopamine (DA) neurons in sporadic Parkinson's disease (PD) display dysregulated gene expression networks and signaling pathways that are implicated in PD pathogenesis. Micro (mi)RNAs are regulators of gene expression, which could be involved in neurodegenerative diseases. We determined the miRNA profiles in laser microdissected DA neurons from postmortem sporadic PD patients' brains and age-matched controls. DA neurons had a distinctive miRNA signature and a set of miRNAs was dysregulated in PD. Bioinformatics analysis provided evidence for correlations of miRNAs with signaling pathways relevant to PD, including an association of miR-126 with insulin/IGF-1/PI3K signaling. In DA neuronal cell systems, enhanced expression of miR-126 impaired IGF-1 signaling and increased vulnerability to the neurotoxin 6-OHDA by downregulating factors in IGF-1/PI3K signaling, including its targets p85β, IRS-1, and SPRED1. Blocking of miR-126 function increased IGF-1 trophism and neuroprotection to 6-OHDA. Our data imply that elevated levels of miR-126 may play a functional role in DA neurons and in PD pathogenesis by downregulating IGF-1/PI3K/AKT signaling and that its inhibition could be a mechanism of neuroprotection.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  6-OHDA neurotoxicity; Cell systems; Dopamine neurons; IGF-1 signaling; Insulin; Laser capture microdissection; PI3K; Parkinson's disease; Postmortem; miR-126; miRNAs

Mesh:

Substances:

Year:  2014        PMID: 24559646      PMCID: PMC3991567          DOI: 10.1016/j.neurobiolaging.2014.01.021

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  60 in total

1.  Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods.

Authors:  L Sastry; T Johnson; M J Hobson; B Smucker; K Cornetta
Journal:  Gene Ther       Date:  2002-09       Impact factor: 5.250

2.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

3.  Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection.

Authors:  Chee Yeun Chung; Hyemyung Seo; Kai Christian Sonntag; Andrew Brooks; Ling Lin; Ole Isacson
Journal:  Hum Mol Genet       Date:  2005-05-11       Impact factor: 6.150

4.  A guide through present computational approaches for the identification of mammalian microRNA targets.

Authors:  Praveen Sethupathy; Molly Megraw; Artemis G Hatzigeorgiou
Journal:  Nat Methods       Date:  2006-11       Impact factor: 28.547

5.  Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo.

Authors:  R Zufferey; D Nagy; R J Mandel; L Naldini; D Trono
Journal:  Nat Biotechnol       Date:  1997-09       Impact factor: 54.908

Review 6.  Etiology and pathogenesis of Parkinson's disease.

Authors:  Anthony H Schapira; Peter Jenner
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

7.  Generalized brain and skin proteasome inhibition in Huntington's disease.

Authors:  Hyemyung Seo; Kai-Christian Sonntag; Ole Isacson
Journal:  Ann Neurol       Date:  2004-09       Impact factor: 10.422

8.  Viral evolution as a tool to improve the tetracycline-regulated gene expression system.

Authors:  Atze T Das; Xue Zhou; Monique Vink; Bep Klaver; Koen Verhoef; Giuseppe Marzio; Ben Berkhout
Journal:  J Biol Chem       Date:  2004-02-02       Impact factor: 5.157

9.  Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery.

Authors:  R Zufferey; T Dull; R J Mandel; A Bukovsky; D Quiroz; L Naldini; D Trono
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

10.  Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists.

Authors:  Steven P Presgraves; Tariq Ahmed; Sabine Borwege; Jeffrey N Joyce
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.978

View more
  44 in total

1.  Targeted Stage-Specific Inflammatory microRNA Profiling in Urine During Disease Progression in Experimental Autoimmune Encephalomyelitis: Markers of Disease Progression and Drug Response.

Authors:  Jaspreet Singh; Mandar Deshpande; Hamid Suhail; Ramandeep Rattan; Shailendra Giri
Journal:  J Neuroimmune Pharmacol       Date:  2015-08-16       Impact factor: 4.147

2.  miR-124-3p attenuates MPP+-induced neuronal injury by targeting STAT3 in SH-SY5Y cells.

Authors:  Lijiao Geng; Wei Liu; Yong Chen
Journal:  Exp Biol Med (Maywood)       Date:  2017-09-29

3.  Midbrain dopamine neurons in Parkinson's disease exhibit a dysregulated miRNA and target-gene network.

Authors:  Christine E Briggs; Yulei Wang; Benjamin Kong; Tsung-Ung W Woo; Lakshmanan K Iyer; Kai C Sonntag
Journal:  Brain Res       Date:  2015-06-03       Impact factor: 3.252

4.  MiR-126 Regulates Growth Factor Activities and Vulnerability to Toxic Insult in Neurons.

Authors:  Woori Kim; Haneul Noh; Yenarae Lee; Jeha Jeon; Arthi Shanmugavadivu; Donna L McPhie; Kwang-Soo Kim; Bruce M Cohen; Hyemyung Seo; Kai C Sonntag
Journal:  Mol Neurobiol       Date:  2014-11-19       Impact factor: 5.590

Review 5.  MicroRNAs in Parkinson's disease.

Authors:  Abhishek Singh; Dwaipayan Sen
Journal:  Exp Brain Res       Date:  2017-05-19       Impact factor: 1.972

6.  Plasma levels of miR-137 and miR-124 are associated with Parkinson's disease but not with Parkinson's disease with depression.

Authors:  Na Li; Xudong Pan; Jingli Zhang; Aijun Ma; Shaonan Yang; Juanjuan Ma; Anmu Xie
Journal:  Neurol Sci       Date:  2017-02-08       Impact factor: 3.307

7.  LncRNA MALAT1 regulates trophoblast cells migration and invasion via miR-206/IGF-1 axis.

Authors:  Hai-Ying Wu; Xiao-Hui Wang; Kan Liu; Jing-Li Zhang
Journal:  Cell Cycle       Date:  2019-11-27       Impact factor: 4.534

8.  Dynamic Changes in miR-126 Expression in the Hippocampus and Penumbra Following Experimental Transient Global and Focal Cerebral Ischemia-Reperfusion.

Authors:  Zhang Hong Xiao; Li Wang; Ping Gan; Jing He; Bing Chun Yan; Li Dong Ding
Journal:  Neurochem Res       Date:  2020-02-17       Impact factor: 3.996

Review 9.  A critical evaluation of neuroprotective and neurodegenerative MicroRNAs in Alzheimer's disease.

Authors:  P Hemachandra Reddy; Sahil Tonk; Subodh Kumar; Murali Vijayan; Ramesh Kandimalla; Chandra Sekhar Kuruva; Arubala P Reddy
Journal:  Biochem Biophys Res Commun       Date:  2016-08-12       Impact factor: 3.575

10.  Late-onset Alzheimer's disease is associated with inherent changes in bioenergetics profiles.

Authors:  Kai-C Sonntag; Woo-In Ryu; Kristopher M Amirault; Ryan A Healy; Arthur J Siegel; Donna L McPhie; Brent Forester; Bruce M Cohen
Journal:  Sci Rep       Date:  2017-10-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.